Status:
UNKNOWN
Acceptability of Self-sampling for Cervical Cancer Screening
Lead Sponsor:
Institut d'Investigació Biomèdica de Bellvitge
Collaborating Sponsors:
Complejo Hospitalario Universitario Insular Materno Infantil
Institut Català de la Salut
Conditions:
HPV-Related Cervical Carcinoma
Self-sampling
Eligibility:
FEMALE
30-65 years
Phase:
NA
Brief Summary
Main objectives: 1.1. To evaluate the use of self-sampling for HPV test in regular attendants of cervical cancer screening as a primary sample collection method. 1.2. To assess the impact on the acc...
Detailed Description
Women aged 30-65 years regular user of cervical cancer screening, not pregnant and with no history of cervical disease are recruited at the cervical cancer screening clinics. Women are recruited in t...
Eligibility Criteria
Inclusion
- Women aged 30 to 65 years (both inclusive) with a adequate prior history of cervical cancer screening (last cytological screening test no more than four years ago).
Exclusion
- Women under 30 years of age.
- Women over 65 years of age.
- Pregnant women.
- Women with hysterectomy.
- Women between 30 and 65 years of age who underwent the last screening test more than four years ago.
- Women between the ages of 30 and 65 who attend for follow-up of some ongoing cervical pathology.
Key Trial Info
Start Date :
November 28 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
1614 Patients enrolled
Trial Details
Trial ID
NCT05314907
Start Date
November 28 2018
End Date
June 1 2022
Last Update
April 14 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Català d'Oncologia
L'Hospitalet de Llobregat, Barcelona, Spain, 08908
2
CAP II Cerdanyola-Ripollet - Institut Català de la Salut
Ripollet, Barcelona, Spain, 08291
3
Complejo Hospitalario Universitario Insular Materno Infantil
Las Palmas de Gran Canaria, Canary Islands, Spain, 35016